Natural health product · NPN 80018200
MÉNOPAUSE
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed April 30, 2010; licence last revised October 13, 2020.
- Natural Product Number (NPN)
- 80018200
- Licence holder
- Distripharm Inc.
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- April 30, 2010
- Licence last revised
- October 13, 2020
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| DL-alpha-Lipoic acid | 150 mg | DL-alpha-Lipoic acid |
| Actaea racemosa | 75 mg | Root |
| Trifolium pratense | 75 mg | Flower buds; 6.3 mg ÉAI |
| Magnesium | 24 mg | Magnesium citrate |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- N/A
Non-medicinal ingredients
Magnesium Stearate; Cellulose, Microcrystalline; Gelatin